|
Horizon Therapeutics Public Ltd Co
Ticker Symbol: HZNP CUSIP: G46188101 Previous CUSIP: 44047T109 Exchange: NGS
Company's Online Profile
BUSINESS: Horizon Therapeutics plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The Company markets 11 medicines through its orphan, rheumatology and primary care business units.
|
IPO - 7/28/2011 - 5.50 Million Shares @ $9.00/share.
Link to IPO Prospectus
Previous Name: Horizon Pharma plc Changed: 5/02/19
Large Cap Stock -
Market Value $ Million
Click for current HZNP price quote from the NASDAQ
Yahoo News Summary for HZNP
YAHOO! Profile for HZNP
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for HZNP
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Foreign Address and Phone Numbers |
| Address: 70 St. Stephen’s Green, Dublin 2, D02 E2X4, Ireland |
| Main Phone Number |
011 353 1 772 2100 |
| Inv Rel Phone Number
|
+353 1 649 8521 |
| Address and Phone Numbers |
| U.S. Representative |
N.A. |
| Address: 520 Lake Cook Road, Suite 520, Deerfield, IL 60015 |
| Main Phone Number |
224-383-3000 |
| Fax Number |
224-383-3001 |
| Investor Contact
Tina Ventura
|
866-286-9155
|
| Toll Free Phone Number |
866-286-9155 |
| CEO - Timothy P. Walbert |
VPF - Aaron Cox |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
